AU2021903786A0 - Novel P2X7 receptor antagonists - Google Patents

Novel P2X7 receptor antagonists

Info

Publication number
AU2021903786A0
AU2021903786A0 AU2021903786A AU2021903786A AU2021903786A0 AU 2021903786 A0 AU2021903786 A0 AU 2021903786A0 AU 2021903786 A AU2021903786 A AU 2021903786A AU 2021903786 A AU2021903786 A AU 2021903786A AU 2021903786 A0 AU2021903786 A0 AU 2021903786A0
Authority
AU
Australia
Prior art keywords
novel
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021903786A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Original Assignee
University of Sydney
Filing date
Publication date
Application filed by University of Sydney filed Critical University of Sydney
Publication of AU2021903786A0 publication Critical patent/AU2021903786A0/en
Priority to PCT/AU2022/051400 priority Critical patent/WO2023092175A1/en
Pending legal-status Critical Current

Links

AU2021903786A 2021-11-24 2021-11-24 Novel P2X7 receptor antagonists Pending AU2021903786A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2022/051400 WO2023092175A1 (en) 2021-11-24 2022-11-23 Novel p2x7 receptor antagonists

Publications (1)

Publication Number Publication Date
AU2021903786A0 true AU2021903786A0 (en) 2021-12-09

Family

ID=

Similar Documents

Publication Publication Date Title
EP4069686A4 (en) Glp-1 receptor agonist
EP3953327A4 (en) Melanocortin-4 receptor agonists
EP3632910A4 (en) Lactam compound as fxr receptor agonist
EP3650449A4 (en) Fxr receptor agonist
EP3923933A4 (en) Pyrrolidine orexin receptor agonists
EP3826990A4 (en) Compounds as neurokinin-1 receptor antagonists and uses thereof
EP3993785A4 (en) Regimens of estrogen receptor antagonists
EP3762386A4 (en) Adenosine receptor antagonists and uses thereof
EP3802500A4 (en) Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
EP4041770A4 (en) Muscarinic acetylcholine m1 receptor antagonists
EP3774813A4 (en) Pyrazolotriazolopyrimidine derivatives as a2a receptor antagonist
IL285024A (en) Thiazolopyridine derivatives as adenosine receptor antagonists
EP3991730A4 (en) Neurokinin-1 antagonist
EP3846806A4 (en) Muscarinic acetylcholine m1 receptor antagonists
EP3965765A4 (en) Opioid receptor antagonist prodrugs
GB201911187D0 (en) Receptor
EP3609868A4 (en) Tetrahydroquinoline derivatives as p2x7 receptor antagonists
EP4006033A4 (en) Adenosine receptor antagonist
EP4061817A4 (en) Adenosine receptor antagonist compounds
EP4054583A4 (en) Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
AU2021903786A0 (en) Novel P2X7 receptor antagonists
EP3750879A4 (en) Prostacyclin receptor agonist
EP4079725A4 (en) N-carboxamidopyrazoline derivative serving as p2x3 receptor antagonist and applications
EP4006032A4 (en) Adenosine receptor antagonist
EP4069702A4 (en) Sstr5 antagonists